ATE467643T1 - Peptide mit proliferationshemmender wirkung - Google Patents

Peptide mit proliferationshemmender wirkung

Info

Publication number
ATE467643T1
ATE467643T1 AT07788860T AT07788860T ATE467643T1 AT E467643 T1 ATE467643 T1 AT E467643T1 AT 07788860 T AT07788860 T AT 07788860T AT 07788860 T AT07788860 T AT 07788860T AT E467643 T1 ATE467643 T1 AT E467643T1
Authority
AT
Austria
Prior art keywords
peptides
proliferation effect
seq
proliferation
effect
Prior art date
Application number
AT07788860T
Other languages
English (en)
Inventor
Eric Ferrandis
Y Ferrer Jose-Antonio Camara
Jean-Gregoire Marin
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of ATE467643T1 publication Critical patent/ATE467643T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07788860T 2006-06-12 2007-06-11 Peptide mit proliferationshemmender wirkung ATE467643T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0605193A FR2902101B1 (fr) 2006-06-12 2006-06-12 Peptides a activite anti-proliferative
PCT/FR2007/000955 WO2007144492A2 (fr) 2006-06-12 2007-06-11 Peptides a activite anti-proliferative

Publications (1)

Publication Number Publication Date
ATE467643T1 true ATE467643T1 (de) 2010-05-15

Family

ID=37546893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788860T ATE467643T1 (de) 2006-06-12 2007-06-11 Peptide mit proliferationshemmender wirkung

Country Status (10)

Country Link
US (1) US7897578B2 (de)
EP (1) EP2041173B1 (de)
JP (1) JP5138680B2 (de)
AT (1) ATE467643T1 (de)
CA (1) CA2654956C (de)
DE (1) DE602007006493D1 (de)
ES (1) ES2342501T3 (de)
FR (1) FR2902101B1 (de)
RU (1) RU2446174C2 (de)
WO (1) WO2007144492A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
US9777039B2 (en) 2012-11-01 2017-10-03 Ipsen Pharma S.A.S. Somatostatin analogs and dimers thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130123A (en) * 1996-11-28 2007-07-24 Roussy Inst Gustave LAG-3 protein mutants, their expression, use and method of production
EP0900841A1 (de) * 1997-06-18 1999-03-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Spleissvarianten von LAG-3
RU2267496C2 (ru) * 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
FR2868781B1 (fr) * 2004-04-13 2008-02-22 Immutep Composition de vaccin comprenant un ligand cmh de classe ii couple a un antigene, procede de preparation et utilisations

Also Published As

Publication number Publication date
RU2008152813A (ru) 2010-07-20
EP2041173B1 (de) 2010-05-12
ES2342501T3 (es) 2010-07-07
WO2007144492A2 (fr) 2007-12-21
FR2902101A1 (fr) 2007-12-14
US20090209466A1 (en) 2009-08-20
CA2654956A1 (fr) 2007-12-21
DE602007006493D1 (de) 2010-06-24
JP2009539947A (ja) 2009-11-19
EP2041173A2 (de) 2009-04-01
US7897578B2 (en) 2011-03-01
WO2007144492A3 (fr) 2008-01-24
CA2654956C (fr) 2016-11-01
RU2446174C2 (ru) 2012-03-27
FR2902101B1 (fr) 2012-12-28
JP5138680B2 (ja) 2013-02-06

Similar Documents

Publication Publication Date Title
UA118167C2 (uk) Пептид та його застосування
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
NZ600690A (en) Fkbp-l and uses thereof
EA201000327A1 (ru) Белок
EA201300455A1 (ru) Полипептиды с пермеазной активностью
EA200901430A1 (ru) Варианты фермента аспарагиназы и их применение
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
DE602005008996D1 (de) Radiofluorierte peptide
NZ596658A (en) Dig-10 insecticidal cry toxins
ZA201001054B (en) Peptide with reduced dimer formation
MX2008009493A (es) Peptido novedoso y uso del mismo.
NZ607069A (en) Modified relaxin polypeptides and their uses
WO2008093058A3 (en) Peptides and their use
BRPI0919696A2 (pt) Polipeptídeo substancialmente purificado, microorganismo recombinante, e, polinucleotídeo isolado.
NZ609216A (en) Anticancer fusion protein
ES2530670T3 (es) Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo
RU2022100555A (ru) Новый пептид
RS51325B (sr) Polipeptidi koji imaju antimikrobno dejstvo i polinukleotidi koji ih kodiraju
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
WO2010057242A3 (de) Vakzin
DE602007001519D1 (de) Zusammensetzung mit mehreren botulinumtoxinen
TR201902131T4 (tr) Enfeksiyöz bronşit virüsünün (IBV) doku tropizmini uzatan mutant diken proteini.
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
ITRM20040349A1 (it) Peptidi antibatterici e loro analoghi.
ATE467643T1 (de) Peptide mit proliferationshemmender wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties